申请人:Albany Molecular Research, Inc.
公开号:US09045501B2
公开(公告)日:2015-06-02
Novel 5-HT3 receptor modulators are disclosed. These compounds are used in the treatment of various disorders, including chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, and irritable bowel syndrome. Methods of making these compounds are also described in the present invention.
本发明公开了新型5-HT3受体调节剂。这些化合物用于治疗各种疾病,包括化疗引起的恶心和呕吐、术后恶心和呕吐以及肠易激综合征。本发明还描述了制备这些化合物的方法。